# TrialScope

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/trialscope

- Industry: Healthcare IT
- Headquarters: Jersey City, US
- Website: www.trialscopeinc.com
- Total disclosed funding: $10M
- Latest round: Series A (May 30, 2014)
- Investors on record: 3

## About

TrialScope Inc. provides advanced clinical trial disclosure software that simplifies the management of trial disclosures, ensuring compliance for pharmaceutical companies and researchers.TrialScope Inc. specializes in clinical trial disclosure solutions, streamlining compliance processes for the pharmaceutical sector. Founded in 2012, the company is based in Jersey City, US. The CEO, Jeff Kozloff, oversees operations, and the firm has successfully raised USD 4 million in its latest funding round in September 2018, making this the total amount raised. TrialScope has completed 2 deals to date.TrialScope Disclose is an innovative clinical trial disclosure software that automates data entry and reporting for various registries, including ClinicalTrials.gov and the Clinical Trials Information System (CTIS). It offers key features such as automated submissions, configurable workflows, and a proprietary disclosure rules library. This solution is utilized by 16 of the top 20 pharmaceutical companies, primarily in North America and Europe, to ensure efficient compliance in clinical trial disclosures.TrialScope Disclose operates on a subscription-based revenue model, securing annual contracts with clients in the pharmaceutical and clinical research sectors. Pricing varies based on user numbers and features utilized, accommodating organizations of different sizes. Revenue is generated through recurring subscriptions, renewals, and consulting services that optimize client disclosure strategies, integrating software with advisory support.Following the recent funding of USD 4 million in September 2018, TrialScope Inc. plans to enhance its product offerings with new features and functionalities designed for the clinical trial landscape. The company aims to expand its market reach, targeting additional regions in Europe and Asia by 2025. This strategic investment will also support the development of advanced analytics tools to further assist clients in managing compliance efficiently.

## Funding rounds

- Series A, May 30, 2014, $10M — Edison Partners, NewSpring, Dublin Capital Partners

## Investors

- Edison Partners (https://capitalatlas.ai/funds/edison-partners) — Series A
- NewSpring (https://capitalatlas.ai/funds/newspring) — Series A
- Dublin Capital Partners (https://capitalatlas.ai/funds/dublin-capital-partners) — Series A